HuGE Literature Finder
Records 1-11
|
Population pharmacokinetics and pharmacogenomics of apixaban in Japanese adult patients with atrial fibrillation.
British journal of clinical pharmacology 2018 Feb . Ueshima Satoshi, Hira Daiki, Kimura Yuuma, Fujii Ryo, Tomitsuka Chiho, Yamane Takuya, Tabuchi Yohei, Ozawa Tomoya, Itoh Hideki, Ohno Seiko, Horie Minoru, Terada Tomohiro, Katsura Toshi |
|
Impact of ABCB1, ABCG2, and CYP3A5 polymorphisms on plasma trough concentrations of apixaban in Japanese patients with atrial fibrillation.
Pharmacogenetics and genomics 2017 Jul . Ueshima Satoshi, Hira Daiki, Fujii Ryo, Kimura Yuuma, Tomitsuka Chiho, Yamane Takuya, Tabuchi Yohei, Ozawa Tomoya, Itoh Hideki, Horie Minoru, Terada Tomohiro, Katsura Toshi |
|
ABCB1 and SLCO1B3 Gene Polymorphisms and Their Impact on Digoxin Pharmacokinetics in Atrial Fibrillation Patients among the Tunisian Population.
Pharmacology 2017 Feb 99 (5-6): 250-258. Tounsi Nejia, Trabelsi Imen, Kerkeni Emna, Grissa Mohamed Habib, Fredj Nizar, Sekma Adel, Mzali Malek, Hellara Ilhem, Monastiri Kamel, Douki Wahiba, Nouira Sem |
|
The impact of CYP4F2, ABCB1, and GGCX polymorphisms on bleeding episodes associated with acenocoumarol in Russian patients with atrial fibrillation.
Drug metabolism and personalized therapy 2016 Sep 31 (3): 173-8. Sychev Dmitriy Alexeyevich, Rozhkov Aleksandr Vladimirovich, Kazakov Ruslan Evgenyevich, Ananichuk Anna Viktorov |
|
Pharmacogenetics of dabigatran etexilate interindividual variability.
Thrombosis research 2016 May 144 1-5. Dimatteo Claudia, D'Andrea Giovanna, Vecchione Gennaro, Paoletti Oriana, Cappucci Filomena, Tiscia Giovanni Luca, Buono Matteo, Grandone Elvira, Testa Sophie, Margaglione Mauriz |
|
ABCB1 gene variants, digoxin and risk of sudden cardiac death in a general population.
Heart (British Cardiac Society) 2015 Nov . Niemeijer Maartje N, van den Berg Marten E, Deckers Jaap W, Aarnoudse Adrianus L H J, Hofman Albert, Franco Oscar H, Uitterlinden André G, Rijnbeek Peter R, Eijgelsheim Mark, Stricker Bruno |
|
Effect of risperidone metabolism and P-glycoprotein gene polymorphism on QT interval in patients with schizophrenia.
The pharmacogenomics journal 2014 Oct 14 (5): 452-6. Suzuki Y, Tsuneyama N, Fukui N, Sugai T, Watanabe J, Ono S, Saito M, Inoue Y, Someya |
|
Prediction of stable acenocoumarol dose by a pharmacogenetic algorithm.
Pharmacogenetics and genomics 2014 Oct 24 (10): 501-13. Jiménez-Varo Enrique, Cañadas-Garre Marisa, Gutiérrez-Pimentel María J, Calleja-Hernández Miguel |
|
Pharmacogenetics role in the safety of acenocoumarol therapy.
Thrombosis and haemostasis 2014 Sep 112 (3): 522-36. Jiménez-Varo E, Cañadas-Garre M, Henriques C I, Pinheiro A M, Gutiérrez-Pimentel M J, Calleja-Hernández M |
|
C3435T polymorphism of MDR1 gene with warfarin resistance.
Clinica chimica acta; international journal of clinical chemistry 2013 Oct 425 34-6. Kim Yeongsic, Smith Andrew, Wu Alan H |
|
Impact of ABCB1 allelic variants on QTc interval prolongation.
Clinical cancer research : an official journal of the American Association for Cancer Research 2011 Feb 17 (4): 937-46. Sissung Tristan M, Gardner Erin R, Piekarz Richard L, Howden Reuben, Chen Xiaohong, Woo Sukyung, Franke Ryan, Clark James A, Miller-DeGraff Laura, Steinberg Seth M, Venzon David, Liewehr David, Kleeberger Steven R, Bates Susan E, Price Douglas K, Rosing Douglas R, Cabell Christopher, Sparreboom Alex, Figg William |
- Page last reviewed:Mar 16, 2019
- Page last updated:Jun 03, 2020
- Content source: